ANGPTL4 inhibits LPL activity and retards lipoprotein catabolism Previous studies have shown that carriers of the ANGPTL4 variant are more likely to have lower triglyceride levels and higher HDL cholesterol levels than noncarriers are and are less likely to have CAD [13]. This evidence concerns the gene LPL and coronary artery disorder.